EGFR and breast cancer: Therefore, the aim of this study was to analyze TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 polymorphisms and their associations with tumor clinicopathological features and clinical outcomes in breast cancer patients.